Oncologix Tech, Inc. (OCLG)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jul 17, 2025
Oncologix Tech Income Statement
Financials in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | 2005 - 2009 |
|---|---|---|---|---|---|---|---|
Period Ending | May '15 May 31, 2015 | Aug '14 Aug 31, 2014 | Aug '13 Aug 31, 2013 | Aug '12 Aug 31, 2012 | Aug '11 Aug 31, 2011 | Aug '10 Aug 31, 2010 | 2005 - 2009 |
| 4.61 | 3.68 | 0.24 | - | - | - | Upgrade | |
Revenue Growth (YoY) | 58.17% | 1405.64% | - | - | - | - | Upgrade |
Cost of Revenue | 3.63 | 3.06 | 0.2 | - | - | - | Upgrade |
Gross Profit | 0.98 | 0.61 | 0.05 | - | - | - | Upgrade |
Selling, General & Admin | 1.51 | 1.13 | 0.33 | 0.13 | 0.2 | 0.19 | Upgrade |
Research & Development | 0.04 | 0.03 | - | - | - | - | Upgrade |
Operating Expenses | 1.57 | 1.19 | 0.34 | 0.13 | 0.2 | 0.19 | Upgrade |
Operating Income | -0.59 | -0.57 | -0.29 | -0.13 | -0.2 | -0.19 | Upgrade |
Interest Expense | -1.25 | -0.81 | -0.19 | -0.04 | -0.03 | -0.08 | Upgrade |
Other Non Operating Income (Expenses) | 0.07 | 0.14 | 0 | - | -0 | -0.41 | Upgrade |
EBT Excluding Unusual Items | -1.77 | -1.24 | -0.47 | -0.17 | -0.23 | -0.69 | Upgrade |
Merger & Restructuring Charges | - | - | -0.17 | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0 | Upgrade |
Gain (Loss) on Sale of Assets | - | -0.03 | - | -0 | - | - | Upgrade |
Other Unusual Items | 0.02 | -0.14 | -0.01 | -0.12 | -0.01 | -0.05 | Upgrade |
Pretax Income | -1.75 | -1.41 | -0.65 | -0.29 | -0.24 | -0.74 | Upgrade |
Earnings From Continuing Operations | -1.75 | -1.41 | -0.65 | -0.29 | -0.24 | -0.74 | Upgrade |
Earnings From Discontinued Operations | - | 0.1 | -0 | - | - | -0 | Upgrade |
Net Income to Company | -1.75 | -1.31 | -0.65 | -0.29 | -0.24 | -0.74 | Upgrade |
Minority Interest in Earnings | - | - | - | 0 | 0 | - | Upgrade |
Net Income | -1.75 | -1.31 | -0.65 | -0.29 | -0.24 | -0.74 | Upgrade |
Net Income to Common | -1.75 | -1.31 | -0.65 | -0.29 | -0.24 | -0.74 | Upgrade |
Shares Outstanding (Basic) | 173 | 103 | 62 | 54 | 48 | 46 | Upgrade |
Shares Outstanding (Diluted) | 173 | 103 | 62 | 54 | 48 | 46 | Upgrade |
Shares Change (YoY) | 97.56% | 65.78% | 13.63% | 13.62% | 4.98% | 41.46% | Upgrade |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.02 | Upgrade |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.02 | Upgrade |
Free Cash Flow | -0.57 | -0.63 | -0.11 | -0.12 | -0.18 | -0.23 | Upgrade |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 | -0.01 | Upgrade |
Gross Margin | 21.30% | 16.71% | 19.88% | - | - | - | Upgrade |
Operating Margin | -12.86% | -15.55% | -117.33% | - | - | - | Upgrade |
Profit Margin | -37.98% | -35.68% | -267.55% | - | - | - | Upgrade |
Free Cash Flow Margin | -12.42% | -17.15% | -43.32% | - | - | - | Upgrade |
EBITDA | -0.57 | -0.55 | -0.28 | -0.13 | -0.2 | -0.19 | Upgrade |
EBITDA Margin | -12.42% | -14.93% | -115.10% | - | - | - | Upgrade |
D&A For EBITDA | 0.02 | 0.02 | 0.01 | 0 | 0 | 0 | Upgrade |
EBIT | -0.59 | -0.57 | -0.29 | -0.13 | -0.2 | -0.19 | Upgrade |
EBIT Margin | -12.86% | -15.55% | -117.33% | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.